Krystal Biotech buy Citigroup Inc.
Start price
06.01.26
/
50%
€216.00
Target price
06.01.27
-
Performance (%)
2.31%
Price
10.04.26
€221.00
Summary
This prediction is currently active. With a performance of 2.31%, the BUY prediction by Citigroup_Inc_ for Krystal Biotech is trending in the right direction. This prediction currently runs until 06.01.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | -2.169% | -2.169% |
| iShares Core DAX® | 2.554% | 0.562% |
| iShares Nasdaq 100 | 2.742% | -0.599% |
| iShares Nikkei 225® | 6.584% | 4.336% |
| iShares S&P 500 | 1.930% | -0.507% |
Comments by Citigroup_Inc_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€233.70
12.01.26
12.01.26
€288.19
12.01.27
12.01.27
-5.43%
10.04.26
10.04.26
Krystal Biotech
Start price
Target price
Perf. (%)
€152.00
27.02.24
27.02.24
€179.60
27.02.25
27.02.25
14.14%
28.02.25
28.02.25